Related MeSH Hierarchy (4)
Diseases [C] » Nervous System Diseases [C10] » Cranial Nerve Diseases » Ocular Motility Disorders » Ophthalmoplegia
Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Paralysis » Ophthalmoplegia
Diseases [C] » Eye Diseases [C11] » Ocular Motility Disorders » Ophthalmoplegia
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Paralysis » Ophthalmoplegia
Description
Paralysis of one or more of the ocular muscles due to disorders of the eye muscles, neuromuscular junction, supporting soft tissue, tendons, or innervation to the muscles. MeSH
Hierarchy View
Subtype Terms (3)
Ophthalmoplegia, Chronic Progressive External
1 approved drug
Supranuclear Palsy, Progressive
50 drugs (24 approved, 26 experimental)
Phase 2 Indicated Drugs (1)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 2 Indications (1)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
